Business
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Bausch Health's gastroenterology business, Salix Pharmaceuticals, recognizes the complexities of ...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness MonthBausch Health's gastroenterology business, Salix Pharmaceuticals, recognizes the complexities of irritable bowel syndrome (IBS) and seeks to make a difference in how the condition is perceived, diagnosed and treated. LAVAL, QC / ACCESS Newswire / April 2, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals (\"Salix\"), today announced the launch of IBS Symptoms Aren't Black and White: Living in the Gray, an authentic storytelling campaign that addresses the complexities of living with irritable bowel syndrome (IBS). Throughout April, which is IBS Awareness Month, Salix will be sharing patient stories on LinkedIn, highlighting the unique journeys of individuals living with IBS.Irritable bowel syndrome is more than just a common condition that affects up to an estimated 10% of the global population - it is a complex condition with unpredictable symptoms that can impact every aspect of patients' lives, including one's physical, emotional, social and professional well-being.1,2 Navigating the road to proper care can be a long and complicated process; Salix seeks to bring greater understanding to help improve how IBS is perceived, diagnosed and treated.\"We recognize that every patient's experience is unique and has the potential to inspire others in the IBS community to seek the care they deserve,\" said Nicola Kayel, Senior Vice President, Marketing, Salix. \"Our campaign, IBS Symptoms Aren't Black & White: Living in the Gray, underscores our ongoing commitment to supporting patients by amplifying their voices to raise visibility, build a community of empowered individuals and destigmatize the narrative that surrounds this condition.\"Many people with IBS agree that their symptoms, such as diarrhea and hard to pass bowel movements, can be hard to talk about, and as a result, unresolved symptoms cause the burden of IBS to persist.2 Patient advocacy group, the International Foundation for Gastrointestinal Disorders (IFFGD), recognizes this obstacle and is partnering with Salix to generate conversation and share authentic stories. By normalizing open and honest discussions about IBS and reducing stigma, Salix and IFFGD hope to motivate patients to talk to their h...